LFCR Q2 2021 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$131M-8.2% YoY

Gross Profit

$21M15.8% margin

Operating Income

-$1M-1.1% margin

Net Income

-$13M-10.2% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-3.5%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$895,000

Balance Sheet

Total Assets

$499M

Total Liabilities

$290M

Stockholders' Equity

$209M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131M	$143M	-8.2%
Gross Profit	$21M	$16M	+33.0%
Operating Income	-$1M	-$6M	+75.7%
Net Income	-$13M	-$7M	-97.3%